ArticleHaematologica2014

Pediatric posttransplant relapsed/refractory B-precursor acute lymphoblastic leukemia shows durable remission by therapy with the T-cell engaging bispecific antibody blinatumomab.

Patrick Schlegel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.